reviewTop 1% cited
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Diabetologia · 2009 · Vol. 52(11) · pp. 2288–2298
Fiona Turnbull✉(The George Institute for Global Health)Carlos Abraira(Veterans Health Administration)Robert J. Anderson(Chicago Department of Public Health)Robert P. Byington(Wake Forest University)John Chalmers(The George Institute for Global Health)William C. Duckworth(Phoenix VA Health Care System)Greg Evans(Wake Forest University)Hertzel C. Gerstein(Hamilton Health Sciences)Rury R. Holman(Oxford Centre for Diabetes, Endocrinology and Metabolism)Thomas Moritz(Edward Hines, Jr. VA Hospital)Bruce Neal(University of Sydney)Toshiharu Ninomiya(The George Institute for Global Health)Anushka Patel(University of Sydney)Sanjoy K. Paul(University of Oxford)F. Travert(Université Paris Cité)Mark Woodward(Icahn School of Medicine at Mount Sinai)
Diabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and LipoproteinsMedicineType 2 diabetesMacrovascular diseaseInternal medicineDiabetes mellitusMyocardial infarctionSubgroup analysisMeta-analysisCardiologyEndocrinology
MeSH terms
Blood GlucoseBlood PressureCholesterolClinical Trials as TopicDiabetes Mellitus, Type 2Diabetic AngiopathiesFastingFollow-Up StudiesGlycated HemoglobinHomeostasisHumansPatient ComplianceTreatment OutcomePatient SelectionRisk Reduction Behavior
Funding
- Eli Lilly and Company
- GlaxoSmithKline
- Sanofi
- Servier
Citations
1,195
FWCI
46.85
field-weighted impact
References
22
Percentile
100%
vs. same field & year
Citations per year
Cited by
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
Heart · 2014 · 609 citations
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
European Heart Journal · 2019 · 4,808 citations
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
European Heart Journal · 2021 · 5,933 citations
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
Circulation Research · 2016 · 1,446 citations
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Stroke · 2014 · 5,167 citations
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Diabetes Care · 2012 · 3,208 citations
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
European Heart Journal · 2013 · 1,949 citations
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
European Heart Journal · 2007 · 3,753 citations
References
Effects of Intensive Glucose Lowering in Type 2 Diabetes
New England Journal of Medicine · 2008 · 7,836 citations
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
New England Journal of Medicine · 2008 · 7,365 citations
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
Diabetes Care · 1993 · 4,087 citations
Global Prevalence of Diabetes
Diabetes Care · 2004 · 15,281 citations
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
BMJ · 1998 · 2,031 citations
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
BMJ · 2000 · 8,937 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.